Analysts Set Solventum Co. (NYSE:SOLV) Price Target at $79.86

Shares of Solventum Co. (NYSE:SOLV) have been given an average recommendation of “Hold” by the ten ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $79.86.

SOLV has been the subject of a number of recent analyst reports. Mizuho upped their price target on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Piper Sandler increased their target price on Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, February 28th. Bank of America lifted their price target on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 26th. Morgan Stanley increased their price objective on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 5th. Finally, Wells Fargo & Company boosted their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th.

Institutional Investors Weigh In On Solventum

A number of institutional investors have recently bought and sold shares of the business. Modus Advisors LLC bought a new position in shares of Solventum during the 4th quarter worth about $25,000. Clarity Asset Management Inc. acquired a new position in Solventum in the fourth quarter worth about $25,000. Stonebridge Financial Group LLC bought a new position in Solventum during the fourth quarter worth about $26,000. Raiffeisen Bank International AG acquired a new stake in Solventum during the fourth quarter valued at approximately $29,000. Finally, True Wealth Design LLC grew its stake in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after purchasing an additional 471 shares during the period.

Solventum Price Performance

Shares of Solventum stock opened at $76.29 on Wednesday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm has a fifty day simple moving average of $75.60 and a 200-day simple moving average of $71.97. The stock has a market capitalization of $13.20 billion and a price-to-earnings ratio of 27.74. Solventum has a 1-year low of $47.16 and a 1-year high of $85.92.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.